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Purpose of review: Malnutrition is a frequent complication and risk factor for 
adverse outcomes in the dialysis population that is often underrecognized and 
neglected. This article reviews published literature on the associations between 
malnutrition, mortality, quality of life and hospitalisations in persons on dialysis in 
order to raise awareness of the importance of preventing and treating it. 
Recent findings: All methods of nutritional assessment namely serum biochemistry, 
body composition, dietary intake, handgrip strength and nutritional scoring tools are 
independently associated with increased mortality in dialysis populations. 
Malnutrition severely affects physical and mental measures of quality of life and 
increases the number and length of hospitalisations in persons receiving dialysis, 
resulting in increased healthcare costs. Worsening of nutritional status is also 
associated with poor survival and higher rates of hospitalisations in this patient 
population. 
Summary: Malnutrition is an unacceptably common complication in dialysis patients 
that is substantially associated with adverse outcomes and higher hospital costs. 
Further interventional studies assessing the impact of preventing and treating 
malnutrition on clinical outcomes are warranted and should be considered a priority. 
 
Keywords: adverse outcomes, end-stage kidney disease, dialysis, malnutrition, 
nutritional status assessment. 
  
Introduction 
Malnutrition is a major and frequent complication in persons with end-stage kidney 
disease (ESKD) receiving dialysis that results from the interaction between 
psychosocial factors, decreased functional capacity, and multiple ESKD-related 
mechanisms, including uremic toxicity, metabolic acidosis, loss of appetite, 
inadequate dietary intake, presence of comorbidities, nutrient losses during dialysis, 
and increased systemic inflammation and oxidative stress, which together lead to 
increased energy expenditure, muscle wasting and hypoalbuminaemia [1]. A number 
of terms have been used to refer to malnutrition and in 2008 the International Society 
of Renal Nutrition and Metabolism therefore suggested a single term, “Protein-
Energy Wasting” (PEW), which provided a more accurate description of the 
association between muscle and energy wasting, inadequate dietary intake, 
systemic inflammation, oxidative stress, hypercatabolism and other metabolic 
abnormalities [2]. For the purpose of this review, the term “malnutrition” will be used 
as synonymous with “PEW”. 
 
According to a meta-analysis of 90 studies conducted in dialysis populations, the 
global prevalence of malnutrition varies between 28% and 54% (median 40%), which 
highlights the magnitude of the problem in this patient population [3**]. Despite the 
fact that malnutrition has been shown to be an independent and strong predictor of 
increased mortality, poor quality of life and higher rates of hospitalisations, resulting 
in increased hospital costs [3**-5], it continues to be underrecognized and neglected 
in the context of ESKD. In order to raise awareness of the importance of preventing 
and treating malnutrition in persons receiving dialysis, we reviewed the increasing 
body of evidence surrounding its association with adverse clinical outcomes. 
 
Methods for nutritional status assessment and associations with mortality 
Multiple methods have been developed for the assessment of nutritional status. 
These vary in their dependence on laboratory testing, specialised equipment and 
staff time but most have been validated by confirmation of an association with 
increased mortality in persons receiving dialysis (Table 1). 
 
1. Biochemistry 
The main biochemical markers used for nutritional assessment in the dialysis 
population are serum albumin, prealbumin, total cholesterol and serum creatinine [2]. 
Among these, hypoalbuminaemia has been the most extensively studied marker of 
malnutrition in persons on dialysis, mainly because of its strong association with 
increased all-cause and cardiovascular mortality [4], and because serum albumin 
levels can be improved by different dietetic interventions [1]. Even though 
prospective studies have not yet investigated whether improvements in serum 
albumin (or any other biochemical markers of malnutrition) result in reduced 
mortality, there is evidence suggesting that a substantial percentage of deaths 
occurring during the first year of haemodialysis (HD) treatment could potentially be 
prevented by modifying important clinical risk factors, including hypoalbuminaemia 
[6*]. An analysis of data from 15,891 incident and 51,565 prevalent HD patients in 
the Dialysis Outcomes and Practice Patterns Study (1996-2015) investigated 
population-attributable fractions (PAF), which consider both the strength of 
association (hazard ratio, HR) and the prevalence of a risk factor, of 12 predictors of 
mortality to determine the percentage of deaths that could theoretically be prevented 
if the risk factor was modified. After dialysis catheter use, serum albumin <3.5 g/dL 
and serum creatinine <6 mg/dL had the largest PAF for 1-year mortality in the 
incident HD population (19% and 12%, respectively). In the prevalent HD cohort, 
hypoalbuminaemia had the highest PAF (15%). More importantly, the combined PAF 
for malnutrition (i.e. hypoalbuminaemia + low serum creatinine) was even higher 
than the combined PAF for inflammation (i.e. high white blood cell count + high 
ferritin) in the incident (29% vs 8%) and prevalent HD populations (20% vs 4%). 
Additionally, in a subgroup analysis of 3,596 incident HD patients who had C reactive 
protein (CRP) measured, the largest PAF was observed for CRP >10 mg/dL (21%), 
followed by dialysis catheter use (20%) and hypoalbuminaemia (19%) [6*]. 
 
2. Dietary intake 
In the dialysis population, food diaries conducted usually over 3 or 7 days are the 
preferred method for the assessment of energy, macronutrient and micronutrient 
intake, while 24-hour dietary recalls and normalised protein catabolic rate (nPCR) 
are alternative methods (Table 1) [4]. Inadequate dietary intake is another important 
marker of malnutrition and predictor of increased mortality in the dialysis population 
[7, 8]. For example, in a 44-month observational study conducted in 305 incident 
peritoneal dialysis (PD) patients, dietary protein intake <0.73 g/kg/d was 
independently associated with a 66% increase in overall mortality and a 2.6-fold 
increase in cardiovascular death [8]. In a 10-year retrospective observational study 
conducted in 144 prevalent HD patients, energy intake <25 kcal/kg/d and protein 
intake <0.8 g/kg/d were significantly associated with increased mortality in 
univariable analysis; however, only energy intake <25 kcal/kg/d was identified as an 
independent determinant of all-cause mortality (HR 1.86, 95%CI 1.02–3.39; p=0.04) 
in a multivariable analysis adjusted for age, sex, Kt/V, diabetes and Charlson 
comorbidity index [7].  
 
3. Body composition 
The most common techniques used for the assessment of body composition in the 
dialysis population are anthropometry and bioelectrical impedance analysis (BIA; 
Table 1). Anthropometry refers to the standard and systematic measurement of 
weight, height, skinfold thicknesses and circumferences to calculate different 
anthropometric indexes and percentages, such as body mass index (BMI), body fat 
percentage and mid-arm muscle circumference. BIA is a technique that can directly 
measure and differentiate between body water, body fat mass and lean body mass 
(i.e. muscle mass) according to their electrical conductivity properties [4].  
 
Decreased body fat and muscle mass are considered risk factors for higher mortality 
in persons receiving dialysis. For example, a 24-month multicentre longitudinal study 
conducted in 2,527 persons on HD observed that low body cell mass index (BCMI), 
which is a marker of muscle mass, was an independent determinant of higher 
mortality (HR 1.7, 95%CI 1.14–2.50; p=0.009), after adjustments for confounders [9]. 
Lower lean tissue index (LTI) and fat tissue index (FTI), markers of muscle and fat 
mass, respectively, have also been shown to be independent predictors of poor 
survival in persons performing PD [10]. 
 
Although BMI is a poor marker of malnutrition when used in isolation [4], some 
studies have shown an independent association between low BMI and poor survival 
[11, 12]. For instance, in a 36-month observational study conducted in 173 persons 
on maintenance HD, BMI <23 kg/m2 was independently associated with an 85% 
higher risk of death, after adjusting for confounders [11]. In a multicentre prospective 
observational study, 697 HD participants were followed-up for 12 months. After 
adjustment for covariates, BMI <18.5 kg/m2 was independently associated with a 
3.9-fold increased mortality risk [12]. This same study also reported that LTI and 
BCMI were significantly lower among non-survivors, that low FTI was an 
independent predictor of overall mortality (HR 3.25, 95%CI 1.33-7.95; p=0.01), and 
that a BMI between 25.0-29.9 kg/m2 showed a reduction of 56% in mortality risk. 
These findings support the results from previous studies showing that higher BMI 
and increased fat stores are associated with better survival in persons on dialysis 
(i.e. an obesity paradox); nevertheless, this survival advantage might only apply to 
those obese dialysis patients whose muscle mass is not depleted, as low muscle 
mass and strength in the setting of excess adiposity (i.e. sarcopenic obesity) is a 
predictor of increased mortality [13].  
 
4. Functional markers 
Handgrip strength (HGS), a measure of muscle function and strength, is a simple, 
reproducible and validated method of nutritional and functional assessment, as well 
as a risk factor for mortality in persons receiving dialysis [14, 15]. A meta-analysis of 
9 prospective cohort studies conducted in both HD and PD populations has reported 
that low HGS was an independent predictor of increased overall mortality (HR 1.88 
95%CI 1.51-2.33; p=0.001) and that each 1-kg unit increase in HGS was 
independently associated with a 5% reduction in the risk of death [15]. 
 
5. Nutritional scoring tools 
These assessment tools use a combination of objective and/or subjective nutritional 
markers in order to minimize the limitations of the methods described above when 
used in isolation [4]. The 7-point scale Subjective Global Assessment (SGA) is the 
most important and validated nutritional assessment tool recommended by national 
and international nutrition guidelines for use in the dialysis population. The SGA 
consists of a comprehensive evaluation of the history of weight loss, changes in 
dietary intake, presence of gastrointestinal symptoms and comorbidities, functional 
capacity, and a physical subjective assessment of subcutaneous fat and muscle 
loss, and presence of oedema. According to the individual ratings of these six 
nutrition-related components, nutritional status is classified into well-nourished (SGA 
scores of 6 or 7), mild-moderate malnutrition (SGA scores of 3-5) or severe 
malnutrition (SGA scores of 1 or 2) [4, 5].  
 
The independent association between malnutrition, as assessed by the 7-point scale 
SGA, and increased mortality was first reported by the Canada-USA Peritoneal 
Dialysis Study Group in 1996 [16]. Since then, several other prospective studies 
have confirmed that the 7-point SGA as well as other nutritional scoring tools are 
independent predictors of poor survival in the dialysis population [4, 11, 17-20]. 
Viramontes Hörner et al. [20] reported for the first time in a prospective study 
conducted in 150 dialysis patients that malnutrition (assessed with 7-point SGA) and 
increased skin autofluorescence (a marker of systemic inflammation and oxidative 
stress) are independently associated with a 2.3-fold and a 44% increase in the risk of 
all-cause mortality, respectively, despite being potentially inter-related [21]. 
 
Rodrigues et al. [11] assessed the prognostic significance of the 7-point SGA and 
the Malnutrition Inflammation Score (MIS) in 173 persons receiving HD. MIS is a 
nutritional scoring tool that includes the 6 core components of the SGA plus BMI, 
serum albumin and total iron binding capacity. The overall MIS score ranges from 0 
to 30; the higher the score the more severe the degree of malnutrition [18]. 
Multivariable Cox proportional hazards models identified an SGA score <5 (HR 2.32 
95%CI 1.27-4.24; p=0.01) and a MIS score >8 (HR 2.09 95%CI 1.20-3.64; p=0.01) 
as independent predictors of increased mortality [11]. In a cohort of 365 incident PD 
patients, malnutrition (SGA score <5) was independently associated with a 78% 
increase in the risk of all-cause mortality after adjusting for potential confounders 
[17].  
 
A multicentre prospective study [18] investigated the predictive value for overall and 
cardiovascular mortality of three nutritional scoring tools (MIS, geriatric nutritional 
risk index [GNRI] and objective score of nutrition on dialysis [OSND]) in a cohort of 
1,025 persons on HD. GNRI is calculated using an equation that includes serum 
albumin and changes in body weight. OSND consists of a combination of 
anthropometric measures (weight loss, BMI, triceps skinfold thickness [TSF] and 
mid-arm circumference [MAC]) and biochemical variables (serum albumin, 
transferrin and cholesterol). In multivariable analysis adjusted for potential 
covariates, one standard deviation increase in MIS was independently associated 
with 35% and 39% higher all-cause and cardiovascular mortality, respectively. 
OSND and GNRI were also independent predictors of increased overall and 
cardiovascular mortality. 
 
The association of another nutritional scoring tool, the nutritional risk index (NRI), 
with all-cause, cardiovascular and infection-related mortality was investigated in a 
Japanese nation-wide prospective cohort study conducted in 48,349 persons 
receiving HD [19]. The NRI comprises BMI, serum albumin, serum creatinine and 
total cholesterol, and it is categorised into three nutritional risk-groups: low-risk 
(score 0-7), medium-risk (score 8-10) and high-risk (score 11-13). After extensive 
adjustments, medium-risk and high-risk groups were independently associated with 
a 96% and a 3.9-fold increase in the risk of overall mortality, respectively. These 
same nutritional-risk groups were independent predictors of higher cardiovascular 
and infection-related mortality. The highest HR was observed in the high-risk group 
for death due to infection (5.56, 95%CI 4.49-6.89).  
 
Change in nutritional status over time has also been associated with all-cause 
mortality during the first year of dialysis initiation. In a multicentre prospective cohort 
study with a median follow-up of 30 months [22*], nutritional status of 914 persons 
receiving dialysis (61% HD) was assessed with 7-point SGA at baseline and at 12 
months after dialysis initiation. In multivariable analysis after adjusting for covariates, 
those participants who were well-nourished initially but became malnourished at 12 
months of starting dialysis (n=48) showed a 2.8-fold increase in the risk of death 
compared to those who stayed well-nourished throughout one year (n=603). 
Conversely, those participants who became well-nourished at 12 months (n=213) 
showed a 65% mortality risk reduction in comparison to those who stayed 
malnourished throughout one year (n=50). 
 
Malnutrition and quality of life 
Health-related quality of life (HRQoL) is another important outcome that is severely 
affected by the presence of malnutrition in persons receiving dialysis [1]. For 
instance, de Roij van Zuijdewijn et al. [23] reported in a univariable analysis that 
malnutrition, as assessed by SGA and MIS, was significantly associated with lower 
physical component score (PCS) and mental component score (MCS) of HRQoL in a 
sample of 489 individuals on HD. Another cross-sectional study conducted in 94 
persons receiving HD observed that a lower SGA score was an independent 
determinant of decreased PCS; however, malnutrition was not found to be 
independently associated with lower MCS, possibly due to the small sample size 
[24]. A cross-sectional analysis based on data from 632 HD patients who took part in 
the PROHEMO study [25] observed that malnourished participants (MIS >6; n=268) 
were more likely to have lower PCS and MCS compared to those who were well-
nourished (adjusted mean difference for PCS and MCS: –3.3 95%CI –1.6 to –4.9;–
2.4 95%CI –0.3 to –4.4, respectively). Several other cross-sectional and prospective 
studies conducted in dialysis populations have confirmed that better nutritional status 
is associated with higher physical and mental measures of HRQoL [14, 26-28]. 
 
Malnutrition, increased hospitalisations and healthcare costs 
In persons receiving dialysis, malnutrition is also associated with higher rates of 
hospitalisation and longer hospital stay [11, 14, 29]. In a sample of 173 participants 
on HD, it was observed that those identified as being malnourished according to the 
SGA and MIS showed 38% and 40% higher risk for hospitalisation events, 
respectively, after adjusting for confounders. Lower HGS and hypoalbuminaemia 
were also identified as independent predictors of increased hospital admissions [11]. 
In another study conducted in 170 persons on HD [14], Poisson regression adjusted 
models identified low muscle strength, as assessed by HGS, and presence of 
sarcopenia (defined as low muscle mass and strength) as independent determinants 
of higher hospitalisation rates. Worsening of nutritional status has also been 
associated with increased number of hospital admissions and length of 
hospitalisation. In a longitudinal study (n=104 HD patients) [29], adjusted regression 
models showed that participants who had an SGA score reduction of >1 units were 
2.1 and 3.7 times more likely to be admitted to hospital and to have longer 
hospitalisations, respectively, compared to those participants whose SGA score 
increased by >1 units.  
 
Increased rates of hospitalisations associated with malnutrition result in a greater 
use of healthcare resources and higher hospital costs. For instance, it has been 
reported that the average annual healthcare cost of disease-related malnutrition in 
England was £19.6 billion in 2011-2012. Additionally, the annual treatment cost of 
persons with malnutrition is three to four times higher than that of well-nourished 
individuals (£7,408 vs £2,155 per subject per year) due to longer, more frequent and 
more expensive hospital stays, as well as long-term care [30]. It has also been 
reported that presence of malnutrition, as assessed by different nutritional scoring 
tools, at hospital admission is an independent predictor of higher hospitalisation 
costs. For example, in a multivariable regression analysis model adjusted for 
patient’s sociodemographic characteristics and comorbidities, severe malnutrition 
assessed with the Patient Generated-SGA independently predicted a 27.5% 
increase in hospital costs [31]. 
 
Interventions to improve nutritional status and outcomes 
Although several randomised controlled clinical trials (RCT) conducted in persons 
receiving dialysis have reported that dietetic interventions can improve nutritional 
markers such as serum albumin, serum prealbumin, nPCR, energy and protein 
intake, BMI, body weight, TSF, MAC and SGA score [1], few studies have 
investigated the effectiveness of nutritional interventions in improving clinical 
outcomes [1, 32, 33]. In a multicentre retrospective study, 3374 HD participants with 
a serum albumin <3.5 g/dL who were enrolled in an 8-month pilot program providing 
oral nutritional supplements (ONS) showed a 69% mortality risk reduction compared 
to matched controls who were not participating in the ONS program [32]. A 6-month 
multicentre, open-label RCT conducted in malnourished (serum albumin <4.0 g/dL 
and BMI <24 kg/m2) PD patients observed that the control group (n=37; dietary 
advice only) showed a significant reduction in PCS of HRQoL, whereas HRQoL 
scores remained unchanged in the intervention group (n=37; dietary advice + protein 
powder supplement) [33]. Several non-randomised retrospective studies have also 
suggested that provision of ONS may improve survival in persons receiving HD [1]. 
These findings emphasize the importance of conducting further well-designed 
prospective trials aiming at investigating the impact of interventions to improve 
malnutrition on clinical outcomes in dialysis populations. 
 
Conclusions 
Malnutrition is an unacceptably frequent complication in persons with ESKD 
receiving dialysis that continues to be associated with substantially increased all-
cause, cardiovascular and infection-related mortality, decreased HRQoL, higher 
rates of hospitalizations and increased healthcare costs. These findings highlight the 
importance of prevention and early detection of malnutrition. Priority should be given 
to prospective trials assessing the impact of preventing and treating malnutrition on 




• Malnutrition is a highly prevalent and major complication in the dialysis 
population that deserves greater attention. 
• Multiple methods to assess nutritional status have been identified as 
independent predictors of increased mortality in persons receiving dialysis.  
• Presence of malnutrition severely affects health-related quality of life and 
increases hospital admissions and length of hospitalisations in this patient 
population, which results in higher hospital costs. 
• Development of malnutrition and/or worsening of nutritional status is also 
associated with increased mortality and hospitalisations. 
• Further well-designed prospective trials aiming at improving nutritional status 
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Table 1. Methods of nutritional status assessment in persons receiving dialysis: pros and cons. 
Method of assessment Strengths  Limitations 
Serum albumin • Independent predictor of higher all-cause and cardiovascular 
mortality 
• Association with increased rates of hospitalisation 
• Easy to measure 
• High reproducibility 
• Responds well to dietetic interventions 
• Systemic inflammation and metabolic 
acidosis decrease hepatic albumin 
synthesis 
• Hypoalbuminaemia is associated with 
fluid overload 
 
Serum prealbumin • Independent determinant of increased mortality 
• Correlation with several other nutritional markers including 
energy and protein intake, as well as body fat and muscle 
mass 
• Levels are decreased in the presence 
of systemic inflammation 
Serum creatinine • Surrogate marker of skeletal muscle mass and dietary protein 
intake 
• Lower creatinine associated with increased risk of death 
• Affected by systemic inflammation 
• Concentration depends on the level of 
residual renal function, dialysis dose 
and endogenous degradation 
Body mass index (BMI) and percentage of 
weight loss over time 
• Convenient, inexpensive and easy to calculate as weight, 
height and time can be automatically transferred to electronic 
medical records 
• BMI and unintentional weight loss have been strongly 
associated with increased mortality risk 
• Can be confounded by the presence 
of fluid overload and lacks the ability 
to differentiate between muscle and 
fat mass.  
• BMI does not distinguish between 
visceral and peripheral body fat 
accumulation and its interpretation 
can be influenced by factors such as 
age, sex and muscle mass 
Anthropometric measurements 
• Mid-arm circumference 
• Skinfold thicknesses – body fat 
percentage 
• Mid-arm muscle circumference 
(MAMC) 
• Simple and cost-effective for assessing nutritional status and 
for indirectly estimating total body fat and muscle mass 
• Association with higher all-cause mortality 
• MAMC is a surrogate marker of muscle mass 
Interpretation of anthropometric 
assessment might be affected by: 
• Lack of anthropometric reference 
standards for the dialysis 
population 
• High inter- and intra-observer 
variability 
• Variable hydration status 
Bioelectrical impedance analysis (BIA) • Quick, safe, convenient and easy to perform technique that 
directly measures and, therefore, differentiates between total 
body water (i.e. extra- and intracellular water), total body fat 
mass and lean body mass (i.e. muscle mass) 
• Estimation of phase angle, a measure of nutritional health of 
muscle cell membranes and total cell integrity, which is 
associated with poor quality of life and is an independent 
predictor of malnutrition, muscle weakness, hospitalisation and 
mortality 
• Low fat and muscle tissue index are also independent 
determinants of increased mortality 
• Need of expert and trained staff 
who can manage and interpret 
data appropriately 
• Fluid overload influences BIA 
measurement, leading to 
inaccurate estimations of muscle 
and fat mass; however, in order 
to improve the accuracy of the 
method, it has been suggested 
that all BIA measurements 
should be performed post 
haemodialysis or with the 
peritoneum drained of dialysis 
fluid 
Dietary intake 
• 24-hour dietary recalls 
• 3 or 7 day-food diaries 
• Normalised protein catabolic rate 
(nPCR) 
• 24-hour dietary recalls: convenient and quick; involve a face to 
face or telephone interview conducted by an experienced 
dietitian who collects precise and comprehensive information 
regarding food and drink intake during a 24-hour period 
• 24-hour dietary recalls rely on 
interviewee’s memory, their 
cooperation and communication 
to provide accurate information, 
their estimation of portion sizes 
• Food diaries: record data for a longer period of time and 
supplementary relevant diet information can be obtained once 
the food diary has been recorded and returned to the dietitian 
• nPCR, a measure of total body nitrogen balance, is a valid and 
clinically useful method of assessment of dietary protein intake 
• Low energy and protein intake (<1.0 g/kg/day in HD and <0.73 
g/kg/day in PD) estimated by either 24-hour dietary recalls, 
food diaries or nPCR are associated with increased overall 
mortality 
and their understanding of the 
questions 
• Risk of incomplete or inaccurate 
description of food/drink intake 
and lack of compliance with the 
instructions for completing food 
diaries 
• nPCR might overestimate or 
underestimate protein intake 
under catabolic or anabolic 
conditions, respectively; nPCR 
depends on daily protein intake 
and it can therefore change 
rapidly from day to day 
Handgrip strength (HGS) • Simple, non-invasive, quick, reliable and validated method of 
nutritional and functional assessment 
• Lower in persons with malnutrition and positively associated 
with serum albumin, serum creatinine and lean body mass as 
assessed by BIA and anthropometry 
• Systemic inflammation does not affect HGS 
• Independent predictor of all-cause mortality and hospitalisation 
• Association with worse quality of life 
• Lack of reference values in the 
dialysis population 
• Inconsistency regarding position 
and time of measurement, as 
well as choice of arm  
7-point scale Subjective Global Assessment 
(SGA) 
• Valid, comprehensive and reliable nutritional scoring tool 
• Recommended by national and international nutrition 
guidelines in the dialysis population 
• Association with several nutritional markers such as serum 
albumin, BIA-phase angle, MAMC, fat percentage and nPCR 
• Accuracy to assess nutritional 
status relies on the dietitian’s 
experience and training to 
interpret the data collected 
• Independent predictor of increased overall, cardiovascular and 
infection-related mortality, as well as decreased quality of life 
• Independent determinant of frequent hospitalisations, 
increased length of hospital stay and higher hospital costs 
 
 
